This inventor holds 2 USPTO granted patents. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1979
Title: Innovations by Bella Kiss: A Pioneer in Dithiocarboxylic Compounds
Introduction
Bella Kiss, a notable inventor hailing from Vecses, Hungary, has made significant contributions to the field of chemistry with her innovative work in dithiocarboxylic acids. With two patents to her name, Bella has focused on creating compounds that have potential therapeutic applications, particularly in relation to dopamine regulation.
Latest Patents
Bella's latest patents revolve around the synthesis of 2-Amino-cyclopent-1-ene-1-dithiocarboxylic acids and their derivatives. These compounds are characterized by their unique molecular structures, wherein R can represent various alkenyl and alkyl groups, tailored for specific therapeutic benefits. Additionally, she has developed new 2-amino-cyclopent-1-ene-thiocarboxylic acid-disulfides that demonstrate inhibition of dopamine-β-hydroxylase, positioning them as promising candidates for medical treatment.
Career Highlights
Bella is affiliated with Richter Gedeon Vegyeszeti Gyar Rt, a prominent pharmaceutical company in Hungary. Her work has been critical in exploring the therapeutic potentials of her patented compounds through rigorous research and development. The innovative nature of her inventions positions her as a significant figure in the field of medicinal chemistry.
Collaborations
Throughout her career, Bella has collaborated with esteemed colleagues, including Gyorgy Matolcsy and Eva Palosi. These partnerships have enriched her work, fostering an environment of creativity and exchanging ideas that further enhance the quality and impact of her research.
Conclusion
Bella Kiss exemplifies a modern inventor whose contributions to the field of dithiocarboxylic acids serve to advance medicinal chemistry. With her patents demonstrating significant therapeutic potential, Bella continues to pave the way for innovative solutions in healthcare. Her collaborations and dedication to research enhance the innovative landscape and inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile